ESRRA and ovarian serous adenocarcinoma: Indeed, we did not identify previously described recurrent fusion transcripts in high grade serous ovarian cancer, such as ESRRA-TEX40 [36] or CDKN2D-WDFY2 [37], which could be due to the slightly different ways by which each study identified its fusion transcripts.